Untreated initial psychosis: Its relation to quality of life and symptom remission in first-episode schizophrenia

American Journal of Psychiatry

Volumn 157, Issue 5, 2000, Pages 808-815

  Ho, Beng Choon ^a   Andreasen, Nancy C ^a   Flaum, Michael ^a   Nopoulos, Peg ^a   Miller, Del ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; SCHIZOPHRENIA; SYMPTOMATOLOGY;

ADULT; AGE OF ONSET; ANTIPSYCHOTIC AGENTS; CONFOUNDING FACTORS (EPIDEMIOLOGY); FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS;

EID: 0034017226     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.157.5.808     Document Type: Article

References (68)

1. Strauss JS, Carpenter WT Jr: Prediction of outcome in schizophrenia, III: five-year outcome and its predictors. Arch Gen Psychiatry 1977; 34:159-163
2. Johnstone EC, Frith CD, Gold A, Stevens M: The outcome of severe acute schizophrenic illnesses after one year. Br J Psychiatry 1979; 134:28-33
3. Moller HJ, von Zerssen D, Werner-Eilert K, Wuschner-Stockheim M: Outcome in schizophrenic and similar paranoid psychoses. Schizophr Bull 1982; 8:99-108
4. McGlashan TH: Predictors of shorter-, medium-, and longer-term outcome in schizophrenia. Am J Psychiatry 1986; 143: 50-55
5. Kay SR, Lindenmayer JP: Outcome predictors in acute schizophrenia: prospective significance of background and clinical dimensions. J Nerv Ment Dis 1987; 175:152-160
6. Prudo R, Blum HM: Five-year outcome and prognosis in schizophrenia: a report from the London Field Research Centre of the International Pilot Study of Schizophrenia. Br J Psychiatry 1987; 150:345-354
7. Goldstein JM: Gender differences in the course of schizophrenia. Am J Psychiatry 1988; 145:684-689
8. Westermeyer JF, Harrow M: Course and outcome in schizophrenia, in Handbook of Schizophrenia: Nosology, Epidemiology and Genetics. Edited by Tsuang MT, Simpson JC. Amsterdam, Elsevier, 1988, pp 205-244
9. Breier A, Schreiber JL, Dyer J, Pickar D: National Institute of Mental Health longitudinal study of chronic schizophrenia: prognosis and predictors of outcome. Arch Gen Psychiatry 1991; 48:239-246
10. Loebel AD, Lieberman JA, Alvir JMJ, Mayerhoff DI, Geisler SH, Szymanski SR: Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992; 149:1183-1188
11. Ram R, Bromet EJ, Eaton WW, Pato C, Schwartz JE: The natural course of schizophrenia: a review of first-admission studies. Schizophr Bull 1992; 18:185-207
12. Addington J, Addington D: Premorbid functioning, cognitive functioning, symptoms and outcome in schizophrenia. J Psychiatry Neurosci 1993; 18:18-23
13. Hwu HG, Tan H, Chen CC, Yeh LL: Negative symptoms at discharge and outcome in schizophrenia. Br J Psychiatry 1995; 166:61-67
14. Szymanski S, Lieberman JA, Alvir JM, Mayerhoff D, Loebel A, Geisler S, Chakos M, Koreen A, Jody D, Kane J, Woerner M, Cooper T: Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995; 152:698-703
15. Bromet EJ, Jandorf L, Fennig S, Lavelle J, Kovasznay B, Ram R, Tanenberg-Karant M, Craig T: The Suffolk County Mental Health Project: demographic, pre-morbid and clinical correlates of 6-month outcome. Psychol Med 1996; 26:953-962
16. Bailer J, Brauer W, Rey ER: Premorbid adjustment as predictor of outcome in schizophrenia: results of a prospective study. Acta Psychiatr Scand 1996; 93:368-377
17. Thara R, Eaton WW: Outcome of schizophrenia: the Madras longitudinal study. Aust NZ J Psychiatry 1996; 30:516-522
18. Wieselgren IM, Lindstrom E, Lindstrom LH: Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia. Acta Psychiatr Scand 1996; 94:311-319
19. Ho BC, Nopoulos P, Flaum M, Arndt S, Andreasen NC: Two-year outcome in first-episode schizophrenia: predictive value of symptoms for quality of life. Am J Psychiatry 1998; 155: 1196-1201
20. Wyatt RJ: The dopamine hypothesis: variations on a theme, in Research in the Schizophrenic Disorders. Edited by Cancro R, Dean SR. Jamaica, NY, Spectrum Publications, 1985, pp 225-247
21. Wyatt RJ: Neuroleptics and the natural course of schizophrenia. Schizophr Bull 1991; 17:325-351
22. Wyatt RJ: Antipsychotic medication and the long-term course of schizophrenia, in Contemporary Issues in the Treatment of Schizophrenia. Edited by Shriqui CL, Nasrallah HA. Washington, DC, American Psychiatric Press, 1995, pp 385-410
23. Wyatt RJ: Early intervention for schizophrenia: can the course of the illness be altered? Biol Psychiatry 1995; 38:1-3
24. Wyatt RJ, Green MF, Tuma AH: Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data. Psychol Med 1997; 27:261-268
25. Waddington JL, Youssef HA, Kinsella A: Sequential cross-sectional and 10-year prospective study of severe negative symptoms in relation to duration of initially untreated psychosis in chronic schizophrenia. Psychol Med 1995; 25:849-857
26. Scully PJ, Coakley G, Kinsella A, Waddington JL: Psychopathology, executive (frontal) and general cognitive impairment in relation to duration of initially untreated versus subsequently treated psychosis in chronic schizophrenia. Psychol Med 1997; 27:1303-1310
27. Waddington JL, Scully PJ, Meagher D, Quinn J, Murphy P, Kinsella A, Mullaney J: Duration of initially untreated psychosis: cognition and domains of psychopathology in the long-term (abstract). Int J Neuropsychopharmacol 1998; 1:S31
28. Browne S, Clarke M, Gervin M, Waddington JL, Larkin C, O'Callaghan E: Duration of initially untreated psychosis: impact on quality of life at first presentation with schizophrenia (abstract). Int J Neuropsychopharmacol 1998; 1:S32
29. McGorry PD, Edwards J, Mihalopoulos C, Harrigan SM, Jackson HJ: EPPIC: an evolving system of early detection and optimal management. Schizophr Bull 1996; 22:305-326
30. May PR, Tuma AH: Treatment of schizophrenia: an experimental study of five treatment methods. Br J Psychiatry 1965; 111:503-510
31. May PR, Tuma AH, Dixon WJ: Schizophrenia - a follow-up study of results of treatment, I: design and other problems. Arch Gen Psychiatry 1976; 33:474-478
32. May PR, Tuma AH, Yale C, Potepan P, Dixon WJ: Schizophrenia - a follow-up study of results of treatment. Arch Gen Psychiatry 1976; 33:481-486
33. May PR, Tuma AH, Dixon WJ, Yale C, Thiele DA, Kraude WH: Schizophrenia: a follow-up study of the results of five forms of treatment. Arch Gen Psychiatry 1981; 38:776-784
34. Lo WH, Lo T: A ten-year follow-up study of Chinese schizophrenics in Hong Kong. Br J Psychiatry 1977; 131:63-66
35. Crow TJ, MacMillan JF, Johnson AL, Johnstone EC: A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986; 148:120-127
36. Rabiner CJ, Wegner JT, Kane JM: Outcome study of first-episode psychosis, I: relapse rates after one year. Am J Psychiatry 1986; 143:1155-1158
37. Inoue K, Nakajima T, Kato N: A longitudinal study of schizophrenia in adolescence, I: the one- to three-year outcome. Jpn J Psychiatry Neurol 1986; 40:143-151
38. Fenton WS, McGlashan TH: Sustained remission in drug-free schizophrenic patients. Am J Psychiatry 1987; 144:1306-1309
39. McEvoy JP, Schooler NR, Wilson WH: Predictors of therapeutic response to haloperidol in acute schizophrenia. Psychopharmacol Bull 1991; 27:97-101
40. Szymanski SR, Cannon TD, Gallacher F, Erwin RJ, Gur RE: Course of treatment response in first-episode and chronic schizophrenia. Am J Psychiatry 1996; 153:519-525
41. Carpenter WT Jr: The risk of medication-free research. Schizophr Bull 1997; 23:11-18
42. Waddington JL, Scully PJ: Untreated psychosis and long-term outcome in schizophrenia (letter). Schizophr Bull 1998; 24: 34-35
43. Carpenter WT Jr: Medication-free research and patient safety (letter). Schizophr Bull 1998; 24:35-36
44. McGlashan TH, Johannessen JO: Early detection and intervention with schizophrenia: rationale. Schizophr Bull 1996; 22:201-222
45. Strauss JS, Carpenter WT Jr: The prediction of outcome in schizophrenia, I: characteristics of outcome. Arch Gen Psychiatry 1972; 27:739-746
46. Lehman AF, Ward NC, Linn LS: Chronic mental patients: the quality of life issue. Am J Psychiatry 1982; 139:1271-1276
47. Awad AG: Quality-of-life issues in medicated schizophrenic patients, in Contemporary Issues in the Treatment of Schizophrenia. Edited by Shriqui CL, Nasrallah HA. Washington, DC, American Psychiatric Press, 1995, pp 735-747
48. Awad AG: Quality of life rediscovered: implications for clinical outcome and health economics in schizophrenia. J Psychiatry Neurosci 1997; 22:229-230
49. Lehman AF, Postrado LT, Rachuba LT: Convergent validation of quality of life assessments for persons with severe mental illnesses. Qual Life Res 1993; 2:327-333
50. Sainfort F, Becker M, Diamond R: Judgments of quality of life of individuals with severe mental disorders: patient self-report versus provider perspectives. Am J Psychiatry 1996; 153: 497-502
51. Flaum MA, Andreasen NC, Arndt S: The Iowa Prospective Longitudinal Study of Recent-Onset Psychoses. Schizophr Bull 1992; 18:481-490
52. Andreasen NC, Flaum M, Arndt S: The Comprehensive Assessment of Symptoms and History (CASH): an instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 1992; 49:615-623
53. Andreasen NC: Psychiatric Status You Currently Have - Baseline Version (PSYCH-BASE). Iowa City, Iowa, University of Iowa, 1989
54. Andreasen NC: Scale for the Assessment of Negative Symptoms (SANS). Iowa City, University of Iowa, 1983
55. Andreasen NC: Scale for the Assessment of Positive Symptoms (SAPS). Iowa City, University of Iowa, 1984
56. Gupta S, Rajaprabhakaran R, Arndt S, Flaum M, Andreasen NC: Premorbid adjustment as a predictor of phenomenological and neurobiological indices in schizophrenia. Schizophr Res 1995; 16:189-197
57. Endicott J, Spitzer RL, Fleiss JL, Cohen J: The Global Assessment Scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry 1976; 33:766-771
58. Bilder RM, Mukherjee S, Rieder RO, Pandurangi AK: Symptomatic and neuropsychological components of defect states. Schizophr Bull 1985; 11:409-419
59. Liddle PF: The symptoms of chronic schizophrenia: a re-examination of the positive-negative dichotomy. Br J Psychiatry 1987; 151:145-151
60. Arndt S, Alliger RJ, Andreasen NC: The distinction of positive and negative symptoms: the failure of a two-dimensional model. Br J Psychiatry 1991; 158:317-322
61. Miller DD, Arndt S, Andreasen NC: Alogia, attentional impairment, and inappropriate affect: their status in the dimensions of schizophrenia. Compr Psychiatry 1993; 34:221-226
62. Hafner H, Maurer K, Loffler W, Riecher-Rossler A: The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993; 162:80-86
63. Angermeyer MC, Klusmann D: The causes of functional psychoses as seen by patients and their relatives, I: the patients' point of view. Eur Arch Psychiatry Neurol Sci 1988; 238:47-54
64. Angermeyer MC, Klusmann D, Walpuski O: The causes of functional psychoses as seen by patients and their relatives, II: the relatives' point of view. Eur Arch Psychiatry Neurol Sci 1988; 238:55-61
65. Angermeyer MC, Matschinger H: Relatives' beliefs about the causes of schizophrenia. Acta Psychiatr Scand 1996; 93:199-204
66. Jorm AF. Korten AE, Jacomb PA, Christensen H, Rodgers B, Pollitt P: "Mental health literacy": a survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Med J Aust 1997; 166:182-186
67. Jorm AF, Korten AE, Jacomb PA, Christensen H, Rodgers B, Pollitt P: Public beliefs about causes and risk factors for depression and schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1997; 32:143-148
68. Rabinowitz J, Bromet EJ, Lavelle J, Severance KJ, Zariello SL, Rosen B: Relationship between type of insurance and care during the early course of psychosis. Am J Psychiatry 1998; 155:1392-1397